摘要
Objective To develop a ultra performance liquid chromatography(UPLC) method for the quality evaluation of Shensong Yangxin Capsule(SYC).Methods The Waters Acquity UPLC HSS T3 column(100 mm × 2.1 mm,1.8μm) was used.Acetonitrile and water containing 0.1% phosphoric acid were used as mobile phases of UPLC with gradient elution.The detection wavelengths were set at 203(ginsenoside Rb1),286(salvianolic acid B),230(paeoniflorin),221(schisantherin A),280(sodium danshensu),327(chlorognenic acid),335(spinosin),and 345nm(berberine hydrochloride),respectively.The flow rate was set at 0.4 mL/min and column temperature was 35 ℃.Results The contents of paeoniflorin,salvianolic acid B,schisantherin A,sodium danshensu,chlorognenic acid,spinosin,berberine hydrochloride,and ginsenoside Rb1were determined from 10 batches of SYC.Conclusion The method of the quality evaluation of SYC has acceptable precision,reproducibility,and stability,which could be used as a new method for the quality control of SYC.
Objective To develop a ultra performance liquid chromatography(UPLC) method for the quality evaluation of Shensong Yangxin Capsule(SYC).Methods The Waters Acquity UPLC HSS T3 column(100 mm × 2.1 mm,1.8μm) was used.Acetonitrile and water containing 0.1% phosphoric acid were used as mobile phases of UPLC with gradient elution.The detection wavelengths were set at 203(ginsenoside Rb1),286(salvianolic acid B),230(paeoniflorin),221(schisantherin A),280(sodium danshensu),327(chlorognenic acid),335(spinosin),and 345nm(berberine hydrochloride),respectively.The flow rate was set at 0.4 mL/min and column temperature was 35 ℃.Results The contents of paeoniflorin,salvianolic acid B,schisantherin A,sodium danshensu,chlorognenic acid,spinosin,berberine hydrochloride,and ginsenoside Rb1were determined from 10 batches of SYC.Conclusion The method of the quality evaluation of SYC has acceptable precision,reproducibility,and stability,which could be used as a new method for the quality control of SYC.
基金
the National Technology Research Program for Creating New Drugs(2011ZX09401-020)
National Basic Research Program of China(973 Program 2012CB518606)
